TY - JOUR
T1 - Effects of protein kinase C activation on the regulation of the stimulus-secretion coupling in pancreatic β-cells
AU - Arkhammar, P.
AU - Nilsson, T.
AU - Welsh, M.
AU - Welsh, N.
AU - Berggren, P. O.
PY - 1989
Y1 - 1989
N2 - Effects of protein kinase C (PKC) activation on the insulin-secretory process were investigated, by using β-cell-rich suspensions obtained from pancreatic islets of obese-hyperglycaemic mice. The phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA), which is known to activate PKC directly, the muscarinic-receptor agonist carbamoylcholine and high glucose concentration enhance the phosphorylation of a specific 80 kDa PKC substrate in the β-cells. At a non-stimulatory glucose concentration, 10 nM-TPA increased insulin release, although there were no changes in either the cytoplasmic free Ca2+ concentration ([Ca2+](i)) or membrane potential, as measured with the fluorescent indicators quin-2 and bisoxonol respectively. At a stimulatory glucose concentration TPA caused a lowering in [Ca2+](i), whereas membrane potential was unaffected. Despite the decrease in [Ca2+](i), there was a large stimulation of insulin release. Addition of TPA lowered [Ca2+](i) also in β-cells stimulated by tolbutamide or high K+, although to a lesser extent than in those stimulated by glucose. There was no effect of TPA on either Ca2+ buffering or the ability of Ins(1,4,5)P3 to release Ca2+ in permeabilized β-cells. However, the phorbol ester inhibited the rise in [Ca2+](i) in response to carbamoylcholine, which stimulates the formation of InsP3, in intact β-cells. Down-regulation of PKC influenced neither glucose-induced insulin release nor the increase in [Ca2+](i). Hence, although PKC activation is of no major importance in glucose-stimulated insulin release, this enzyme can serve as a modulator of the glucose-induced insulin-secretory response. Such a modulation involves mechanisms promoting both amplification of the secretory response and lowering of [Ca2+](i).
AB - Effects of protein kinase C (PKC) activation on the insulin-secretory process were investigated, by using β-cell-rich suspensions obtained from pancreatic islets of obese-hyperglycaemic mice. The phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA), which is known to activate PKC directly, the muscarinic-receptor agonist carbamoylcholine and high glucose concentration enhance the phosphorylation of a specific 80 kDa PKC substrate in the β-cells. At a non-stimulatory glucose concentration, 10 nM-TPA increased insulin release, although there were no changes in either the cytoplasmic free Ca2+ concentration ([Ca2+](i)) or membrane potential, as measured with the fluorescent indicators quin-2 and bisoxonol respectively. At a stimulatory glucose concentration TPA caused a lowering in [Ca2+](i), whereas membrane potential was unaffected. Despite the decrease in [Ca2+](i), there was a large stimulation of insulin release. Addition of TPA lowered [Ca2+](i) also in β-cells stimulated by tolbutamide or high K+, although to a lesser extent than in those stimulated by glucose. There was no effect of TPA on either Ca2+ buffering or the ability of Ins(1,4,5)P3 to release Ca2+ in permeabilized β-cells. However, the phorbol ester inhibited the rise in [Ca2+](i) in response to carbamoylcholine, which stimulates the formation of InsP3, in intact β-cells. Down-regulation of PKC influenced neither glucose-induced insulin release nor the increase in [Ca2+](i). Hence, although PKC activation is of no major importance in glucose-stimulated insulin release, this enzyme can serve as a modulator of the glucose-induced insulin-secretory response. Such a modulation involves mechanisms promoting both amplification of the secretory response and lowering of [Ca2+](i).
UR - http://www.scopus.com/inward/record.url?scp=0024456533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024456533&partnerID=8YFLogxK
U2 - 10.1042/bj2640207
DO - 10.1042/bj2640207
M3 - Article
C2 - 2690820
AN - SCOPUS:0024456533
VL - 264
SP - 207
EP - 215
JO - Biochemical Journal
JF - Biochemical Journal
SN - 0264-6021
IS - 1
ER -